Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
Yujeong Moon, Seong Ik Jeon, Man Kyu Shim, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 411-411
Open Access | Times Cited: 21

Showing 21 citing articles:

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy
Chao Wang, Yujing Zhang, Wujun Chen, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 27
Stimuli-activatable PROTACs for precise protein degradation and cancer therapy
Jing Gao, Lei Yang, Shumin Lei, et al.
Science Bulletin (2023) Vol. 68, Iss. 10, pp. 1069-1085
Closed Access | Times Cited: 34
Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Wan Su Yun, Soo Hyun Kim, Dong-Kwon Lim, et al.
Nanomaterials (2023) Vol. 13, Iss. 15, pp. 2225-2225
Open Access | Times Cited: 28
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Yuqing Lu, Yuewen Yang, Guanghao Zhu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3360-3382
Open Access | Times Cited: 14
Potential of the nanoplatform and PROTAC interface to achieve targeted protein degradation through the Ubiquitin–Proteasome system
Hanshu Xie, Chao Zhang
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116168-116168
Closed Access | Times Cited: 5
Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment
Lianlian Fan, Weifang Tong, Anhui Wei, et al.
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133680-133680
Open Access | Times Cited: 4
Integrating Proteolysis‐Targeting Chimeras (PROTACs) with Delivery Systems for More Efficient and Precise Targeted Protein Degradation
Jiachan Lin, Zirui Chen, Dan Zhang, et al.
Macromolecular Rapid Communications (2025)
Closed Access
NSD3: Advances in cancer therapeutic potential and inhibitors research
Siyu Xiu, Xiaowei Chi, Zhenyu Jia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115440-115440
Closed Access | Times Cited: 11
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Recent advances in dual PROTACs degrader strategies for disease treatment
Jianyu Liu, Yanzhuo Liu, Jiao Tang, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116901-116901
Closed Access | Times Cited: 2
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 1
N/C-degron pathways and inhibitor development for PROTAC applications
Zhibin Wu, Yunyuan Huang, Ke Liu, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2023) Vol. 1867, Iss. 1, pp. 194952-194952
Closed Access | Times Cited: 3
Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: Towards development of non-invasive early detection strategies
Simon N. Mbugua
Dyes and Pigments (2023) Vol. 219, pp. 111603-111603
Closed Access | Times Cited: 3
Design of Mdm2 Protac Degraders with a Built-In Tumor-Targeting Ability
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
(2024)
Closed Access
Adsorption of Dacarbazine as Anticancer Drug on Si60, C60, B30N30, Sc-Si60, Sc-C60, Sc-B30N30 Nanocages
Junjuan Zhang, Xiangtao Yu, Jing Wang, et al.
Silicon (2024) Vol. 16, Iss. 15, pp. 5563-5570
Closed Access
Novel Technologies in PROTAC Design
Keerti Jain, Sukuru Chinna Reddy, Sreevardhan Moode, et al.
(2024), pp. 89-115
Closed Access
Delivery Systems: Miniaturised PROTAC, Nano PROTAC, and Aptamer-Based RNA PROTAC
Manish P. Patel, Hard K. Kalyani, Kashyap M. Patel, et al.
(2024), pp. 367-385
Closed Access
Design of Murine Double Minute 2 Proteolysis Targeting Chimera Degraders with a Built-In Tumor-Targeting Ability
Zhuqian Wang, Siran Yue, Xinxin Chen, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 18865-18882
Closed Access
Dysregulation of ubiquitination modification in renal cell carcinoma
Hongjie You, Hui Zhang, Xiaofeng Jin, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
Exosome-mediated intercellular communication and PROTACs delivery: A Dual Approach for Precision Therapy in Colon Cancer
Popat Mohite, Abhijeet Puri, Shubham Munde, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106596-106596
Closed Access
WITHDRAWN: Targeted protein degradation: A promising approach for cancer treatment
Muhammad Zafar Irshad Khan, Adila Nazli, Iffat Naz, et al.
Journal of Pharmaceutical Analysis (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top